ORCHID PHARMA
Back to Income Statement
|
ORCHID PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹46 Cr | ₹-1.95 Cr | ₹-117 Cr | ₹-131 Cr | ₹69 Cr |
What is the latest Consolidated Net Profit of ORCHID PHARMA ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹46 Cr |
Mar2023 | ₹-1.95 Cr |
Mar2022 | ₹-117 Cr |
Mar2021 | ₹-131 Cr |
Mar2020 | ₹69 Cr |
How is Consolidated Net Profit of ORCHID PHARMA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹46 Cr | Positive | |
Mar2023 | ₹-1.95 Cr | Negative | |
Mar2022 | ₹-117 Cr | Negative | |
Mar2021 | ₹-131 Cr | Negative | |
Mar2020 | ₹69 Cr | - |
Compare Consolidated Net Profit of peers of ORCHID PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ORCHID PHARMA | ₹3,794.4 Cr | -1.3% | -0.1% | -45.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,115.0 Cr | 3.5% | -3.4% | -5.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,735.0 Cr | 3.7% | -10.2% | 25.6% | Stock Analytics | |
CIPLA | ₹126,313.0 Cr | 5.3% | 6.1% | -1.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,592.0 Cr | 1.4% | 4.6% | 7.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,095.0 Cr | 3.9% | 0% | -9.9% | Stock Analytics |
ORCHID PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ORCHID PHARMA | -1.3% |
-0.1% |
-45.4% |
SENSEX | -0% |
-2.4% |
1.2% |
You may also like the below Video Courses